On August 5, 2026, the National Company Law Appellate Tribunal conducted hearings in a complex corporate legal dispute involving Assam Medical Corporation Private Limited. The proceedings examined four distinct appeals challenging a previous order issued by the Guwahati Bench of the National Company Law Tribunal on January 13, 2020. Central to the legal scrutiny is the contentious sale and transfer of company shares to incoming investor groups.
The underlying litigation originates from a corporate petition filed in 2018 regarding the governance and equity distribution within the healthcare enterprise. According to official records, the initial NCLT ruling had set aside the transfer of 117 shares executed by the Dr. Kali Charan Das Trust. Multiple stakeholders subsequently approached the appellate authority to contest various aspects of that foundational decision.
The legal challenge comprises four interconnected appeals filed by different parties invested in the corporate structure. Company Appeal No. 102 was brought forward by the incoming investors from the Agarwal and Khemani groups. Meanwhile, the corporate entity itself and the Dr. Kali Charan Das Trust filed separate challenges under Appeal Nos. 103 and 104 to defend the share transactions.
A fourth challenge, designated as Company Appeal No. 113, was submitted by minority shareholders Mr. Balendra Choudhury and Mr. SMB Baruah. Official data shows these appellants argued that the tribunal erred by validating the sale of an additional 135 shares while invalidating the trust-held equity. They contended that no legal distinction should apply between the two blocks of transferred shares.
Corporate law experts note that appellate rulings in such multi-party shareholder disputes significantly influence governance standards and equity transfer protocols across regional enterprises. The final adjudication is expected to provide definitive clarity on the validity of share transfers and minority shareholder protections under corporate law. Industry observers are closely monitoring the tribunal’s hybrid-mode proceedings for potential precedents.
As the legal battle progresses, stakeholders await the formal judgment from the technical and judicial members presiding over the case. Future hearings will likely focus on reconciling the disparate arguments presented by the incoming shareholders, the trust, and the contesting minority members. Observers advise tracking official tribunal announcements for updates on the final verdict and its implementation timeline.
Disclaimer: This article is published for general news and informational purposes only. While every effort has been made to ensure accuracy, readers are advised to verify important information from official sources. The publisher shall not be responsible for any loss or inconvenience arising from reliance on the information published.
